Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Features and Roles of T Helper 9 Cells and Interleukin 9 in Immunological Diseases Publisher Pubmed



Yazdani R1 ; Shapoori S2 ; Rezaeepoor M2 ; Sanaei R3 ; Ganjalikhanihakemi M2 ; Azizi G4, 5 ; Rae W6 ; Aghamohammadi A1 ; Rezaei N1, 7, 8
Authors
Show Affiliations
Authors Affiliations
  1. 1. Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Science, Tehran, Iran
  2. 2. Department of Immunology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Department of Immunology, School of Medicine, Iran University of Medical Science, Tehran, Iran
  4. 4. Non-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran
  5. 5. Department of Laboratory Medicine, Imam Hassan Mojtaba Hospital, Alborz University of Medical Sciences, Karaj, Iran
  6. 6. Department of Immunology, MP8, University Hospital Southampton NHS Foundation Trust, Tremona Road, Southampton, SO16 6YD, Hampshire, United Kingdom
  7. 7. Department of Immunology, School of Medicine, Tehran University of Medical Science, Tehran, Iran
  8. 8. Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran

Source: Allergologia et Immunopathologia Published:2019


Abstract

T helper 9 (T H 9) cells are considered as newly classified helper T cells that have an important role in the regulation of immune responses. Since these cells preferentially produce IL-9, these cells are termed T H 9 cells. Recently, the role of T H 9 and its signature cytokine (IL-9) has been investigated in a wide range of diseases, including autoimmunity, allergy, infections, cancer and immunodeficiency. Herein, we review the most recent data concerning T H 9 cells and IL-9 as well as their roles in disease. These insights suggest that T H 9 cells are a future target for therapeutic intervention. © 2018 SEICAP
2. Th9 Cells As a New Player in Inflammatory Skin Disorders, Iranian Journal of Allergy# Asthma and Immunology (2019)
3. The Roles of Cd4+ T-Cells in Tumor Immunity, Cancer Immunology: A Translational Medicine Context# Second Edition (2020)
7. The Clinical and Immunological Features of Patients With Primary Antibody Deficiencies, Endocrine# Metabolic and Immune Disorders - Drug Targets (2018)
Experts (# of related papers)
Other Related Docs
11. Role of Rare Immune Cells in Common Variable Immunodeficiency, Pediatric Allergy and Immunology (2022)
15. The Newly Identified T Helper 22 Cells Lodge in Leukemia, International Journal of Hematology-Oncology and Stem Cell Research (2015)
16. Role of Apoptosis in the Pathogenesis of Common Variable Immunodeficiency (Cvid), Endocrine# Metabolic and Immune Disorders - Drug Targets (2017)
23. Autoimmunity in Primary Antibody Deficiencies, International Archives of Allergy and Immunology (2017)
28. The Role of Innate Lymphoid Cells in Health and Disease, Journal of Cellular Physiology (2018)
31. Cancer Nanomedicine: Special Focus on Cancer Immunotherapy, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers# Second Edition (2020)
32. Approach to the Management of Autoimmunity in Primary Immunodeficiency, Scandinavian Journal of Immunology (2017)
36. A Review on Defects of Dendritic Cells in Common Variable Immunodeficiency, Endocrine# Metabolic and Immune Disorders - Drug Targets (2017)
37. Infectious and Noninfectious Pulmonary Complications in Patients With Primary Immunodeficiency Disorders, Journal of Investigational Allergology and Clinical Immunology (2017)
41. Adaptive Immunity, Encyclopedia of Infection and Immunity (2022)
43. Two Faces of Lrba Deficiency in Siblings: Hypogammaglobulinemia and Normal Immunoglobulin Levels, Journal of Investigational Allergology and Clinical Immunology (2018)
44. Survivin and Autoimmunity; the Ins and Outs, Immunology Letters (2018)
48. Gut Microbiome and Multiple Sclerosis: New Insights and Perspective, International Immunopharmacology (2020)